Venlafaxine Hydrochloride
Product Images NDC 45865-643

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 45865-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp37.5 (643 60)

This is a description of the medication Venlafaxine HCL ER in the form of capsules of 37.5 mg, which is a generic alternative to Effexor XR. Each capsule contains the equivalent of 157.5 mg of Venafaxne. The medication is made by Avotex Corporation in Weston, FL. It is recommended to take the medication as directed by a physician and with food. The label warns that the medication may cause dizziness or drowsiness, and patients should avoid alcohol. The text includes additional information in Spanish.*

FDA Label Image

Pdp75 (647 60)

Generic for Effexor XR, Venlafaxine HCL ER capsules, 75mg each, with a total of 60 capsules per bottle. Each capsule contains Venlafaxine equivalent to 73mg. These capsules may cause dizziness or drowsiness, avoid alcohol and take with food. Follow your physician's instructions for dosage.*

FDA Label Image

Figure1 (Figure1)

This appears to be a drug interaction report with some chemical and medical terminology, but the output is not clear enough to provide a useful description.*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

This text appears to contain a list of descriptions and recommendations related to patients with liver impairments and certain genetic polymorphisms. There are also mentions of an analyte named "snistaine" and "sinitasine". The text features recommendations for adjusting medication doses for patients with particular conditions, as well as suggestions for monitoring liver function and potential metabolic issues.*

FDA Label Image

Structure (Structure)

The text is not useful as it contains only random characters and a partial word. Thus, it is not-available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.